Data cannot be shared publicly beyond the Collaborative Individual Participant Data Meta-analysis of Sleep and Stillbirth (CRIBSS) group as no individual participating study obtained consent from participants to make the data publically available. Furthermore, because stillbirth is uncommon there is potential for participants to be identifiable. Contact information for the CRIBSS Data Access Committee is The CRIBSS Data Centre, Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland Mail Centre, Auckland 1142.

Introduction {#sec005}
============

The loss of a baby from stillbirth has detrimental consequences for the family and the community \[[@pone.0230861.ref001]\]. The causes of many stillbirths are unexplained \[[@pone.0230861.ref002], [@pone.0230861.ref003]\]. Sleep-disordered breathing (SDB), ranging from snoring to obstructive sleep apnoea (OSA), is common during pregnancy. The cardinal symptom, habitual snoring ≥3 nights per week, affects up to 35% of women in the third trimester \[[@pone.0230861.ref004], [@pone.0230861.ref005]\], and up to 85% of women with pre-eclampsia \[[@pone.0230861.ref006]\], while objective measures of OSA are estimated to affect between 8% and 26% of pregnant women \[[@pone.0230861.ref007], [@pone.0230861.ref008]\]. SDB is a risk factor for adverse pregnancy outcomes, including gestational hypertension and pre-eclampsia \[[@pone.0230861.ref004], [@pone.0230861.ref009], [@pone.0230861.ref010]\], hyperglycaemia \[[@pone.0230861.ref011]--[@pone.0230861.ref013]\], impaired fetal growth \[[@pone.0230861.ref014]--[@pone.0230861.ref019]\], and early-term and/or preterm birth \[[@pone.0230861.ref009], [@pone.0230861.ref014], [@pone.0230861.ref020]--[@pone.0230861.ref022]\]. SDB is exacerbated by obesity, advanced gestation, and the supine sleep position \[[@pone.0230861.ref023]\], all of which are themselves associated with an increased risk of late stillbirth \[[@pone.0230861.ref024]\]. Therefore, pregnant women with SDB may have an increased risk of late stillbirth (≥28 weeks' gestation) and this risk may be magnified if women settle to sleep supine, however the data is lacking.

Importantly, the association between SDB and maternal sleep patterns (sleep quality, sleep duration, restless sleep, daytime sleepiness, and daytime naps) with late stillbirth is inconsistent across studies. A meta-analysis \[[@pone.0230861.ref025]\], which included the comparison of stillbirth in women with and without SDB as an outcome measure, using subjective (self-reported snoring) \[[@pone.0230861.ref026], [@pone.0230861.ref027]\] and objective (OSA) \[[@pone.0230861.ref009], [@pone.0230861.ref028], [@pone.0230861.ref029]\] measurements, reported no association between SDB and stillbirth. The relationship between sleep duration and late stillbirth was reported in several case-control \[[@pone.0230861.ref026], [@pone.0230861.ref030]--[@pone.0230861.ref032]\] and cross sectional studies \[[@pone.0230861.ref033]\], however, the results are not consistent in identifying an association. Subjective sleep quality was also not associated with stillbirth in a cross-sectional \[[@pone.0230861.ref033]\] and case-control \[[@pone.0230861.ref032]\] study. Other case-control studies \[[@pone.0230861.ref026], [@pone.0230861.ref030]\] reported that daily naps, compared to no naps, were independently associated with late stillbirth. These inconsistencies may be due to differing measurements of these aspects of maternal sleep between studies, or because some studies did not adjust for potential confounders (such as maternal body mass index \[BMI kg/m2\] and maternal age). Furthermore, as late stillbirth is a relatively rare event, ranging from 1·3 to 8·8/1000 births in high-income countries \[[@pone.0230861.ref003]\], individual studies have been underpowered to investigate interactions between supine going-to-sleep position and late stillbirth in women with SDB compared to those without.

The triple risk model \[[@pone.0230861.ref034]\] suggests that late stillbirth may be the culmination of an interplay between stressors (e.g. SDB, supine going-to-sleep position), maternal risk factors (e.g. obesity, age), and fetal-placental vulnerability (e.g. impaired fetal growth, placental dysfunction). Exploration of possible biological pathways \[[@pone.0230861.ref035]\] of the association of adverse pregnancy outcomes related to SDB suggests that there are multifactorial mechanisms, including sympathetic activation, oxidative stress, inflammation, and endothelial dysfunction, which contribute to maternal cardiovascular dysfunction, metabolic derangement, placental dysfunction, and fetal compromise. Thus, it is plausible that when a mother is in the supine position in late pregnancy and there is reduced maternal-fetal blood flow from aortocaval compression \[[@pone.0230861.ref036], [@pone.0230861.ref037]\], the addition of partial airway collapse with SDB may exacerbate fetal compromise in a vulnerable fetus.

Since SDB and maternal sleep patterns are potentially modifiable during pregnancy (such as lateral position for supine-dependent snoring, continuous positive airway pressure for OSA, and frequency of daytime naps), it is possible that screening and management of these aspects of maternal sleep during pregnancy may support reduction in the rate of late stillbirth. However, there is a need to assess the current evidence from individual studies that have collected data on maternal sleep and stillbirth to determine if they are associated with late stillbirth.

We established the Collaborative Individual Participant Data (IPD) Meta-analysis of Sleep and Stillbirth (CRIBSS) group to address if maternal going-to-sleep position was associated with late stillbirth. This included pre-specified secondary questions on symptoms of SDB and maternal sleep patterns \[[@pone.0230861.ref038]\], including 1) is SDB associated with late stillbirth, and 2) is supine going-to-sleep position associated with greater risk of late stillbirth in women with SDB compared to those without?

Materials and methods {#sec006}
=====================

The study population comprised cases with late stillbirth and controls with ongoing pregnancies from the CRIBSS data. This IPD meta-analysis was registered with the PROSPERO register of systematic reviews (CRD42017047703) and followed the IPD meta-analysis protocol \[[@pone.0230861.ref038]\], search strategy \[[@pone.0230861.ref024]\], risk of bias for non-randomised studies (ROBINS-E) tool \[[@pone.0230861.ref039]\], and published results \[[@pone.0230861.ref024]\]. Five international case-control studies \[[@pone.0230861.ref026], [@pone.0230861.ref027], [@pone.0230861.ref030]--[@pone.0230861.ref032]\] that collected maternal going-to-sleep position and late stillbirth data were included in this pooled IPD meta-analysis.

Participant level inclusion criteria were singleton, non-anomalous pregnancy, ≥28 weeks' gestation. Exclusion criteria were multiple pregnancy, major congenital abnormality, gestation \<28 weeks' when pregnancy sleep data was collected, termination of pregnancy at ≥28 weeks', and receiving an intervention that may have affected going-to-sleep position. Maternal sleep data were collected by self-report via face-to-face interview \[[@pone.0230861.ref026], [@pone.0230861.ref027], [@pone.0230861.ref030], [@pone.0230861.ref031]\] or online survey \[[@pone.0230861.ref032]\] within six weeks after stillbirth in cases or at a matched gestation in controls.

Late stillbirth, using the international definition of stillbirth \[[@pone.0230861.ref040]\], "a baby born with no signs of life at or after 28 weeks' gestation," was the primary outcome. The analysis included intrapartum stillbirth, with the rationale that the exact time of the stillbirth may be uncertain and that SDB may result in a vulnerable baby that is unable to tolerate labour.

Data analysis {#sec007}
-------------

This was a prespecified secondary analysis of an IPD meta-analysis that investigated maternal going-to-sleep position and late stillbirth, with a one-stage approach stratified by study and site. A detailed statistical analysis plan, prior to the analysis, has been published.^25^ Prespecified potential covariates were: maternal age, earliest pregnancy BMI, ethnicity, parity, education level, marital status, pre-existing hypertension or diabetes, smoking, recreational drug use, supine going-to-sleep position, fetal movements, infant birthweight by customised centiles, and measures of SDB and sleep patterns ('any' snoring, habitual snoring, the Berlin Questionnaire \[BQ\], Epworth Sleepiness Scale \[ESS\], sleep quality, sleep restlessness, and sleep duration). Frequency of getting up to use the toilet and daytime naps were also included as these are previously reported \[[@pone.0230861.ref026], [@pone.0230861.ref030]--[@pone.0230861.ref032]\] independent risk factors for late stillbirth. Where data exists for multiple time frames, only data for the month prior to the stillbirth were used in the analysis. In cases where the last month data were not available, data collected for the 'last week' \[[@pone.0230861.ref031]\] were used.

There are currently no validated tools for SDB screening during pregnancy, therefore we investigated habitual snoring, a positive BQ \[[@pone.0230861.ref041]\], and daytime sleepiness using the ESS \[[@pone.0230861.ref042]\] as proxy indicators. The BQ \[[@pone.0230861.ref041]\] was developed to identify individuals at risk of OSA in non-pregnant primary care populations and has three categories 1) snoring frequency, loudness, and witnessed apnoea, 2) daytime sleepiness, and 3) BMI \>30 and hypertension, with a positive BQ requiring two positive categories. The ESS \[[@pone.0230861.ref042]\] is a subjective measure of daytime sleepiness with eight questions about the likelihood of dozing off in specified situations, ranging from unlikely (in a car stopped for a few minutes in traffic) to highly likely (lying down to rest in the afternoon). The ESS is coded as 0 = never doze, 1 = slight chance, 2 = moderate chance, and 3 = high chance, with a positive ESS screen indicating clinical levels of daytime sleepiness defined as ≥10.

Data on the usual duration of overnight sleep were also collected. The reference for sleep duration was defined as 6 to 9 hours, with duration categorised as \<6, 6--9, or \>9 hours. Restless sleep and sleep quality were each single questions, with 'average' restlessness and 'average' sleep quality as the reference group.

A one-stage approach to meta-analysis was used, so that the data from the participating eligible studies ([Table 1](#pone.0230861.t001){ref-type="table"}) were included in a single model. Logistic regression models were used for the binary outcome. A fixed study effect and study site effect were included in the model specification as strata. Univariable analysis was performed to evaluate the association between the measures of SDB and maternal sleep patterns and the odds of late stillbirth. A multivariable model was developed incorporating prespecified covariates \[[@pone.0230861.ref038]\] available in all the studies (Appendix 1 in the [S1 Protocol](#pone.0230861.s004){ref-type="supplementary-material"}) and measures of SDB and maternal sleep patterns that were significant in univariable analysis ([Table 1](#pone.0230861.t001){ref-type="table"}). Some covariates (habitual snoring, the BQ, sleep quality, restless sleep, daytime naps, daytime sleepiness using the ESS, and getting up to use the toilet) were not available in all participating studies ([S1 Fig](#pone.0230861.s001){ref-type="supplementary-material"}).

10.1371/journal.pone.0230861.t001

###### Study level characteristics and measured sleep-related factors in participating studies.

![](pone.0230861.t001){#pone.0230861.t001g}

  Study level characteristics             The Auckland Stillbirth Study                                                                                                                   Sydney Stillbirth Study                                                                                                              New Zealand Multicentre Stillbirth Study                                                                        Midlands and North of England Stillbirth Study                                                                Study of Trends and Associated Risks for Stillbirth Study
  --------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------
  Location                                Auckland, New Zealand                                                                                                                           Sydney, Australia                                                                                                                    New Zealand                                                                                                     United Kingdom                                                                                                International
  Years of recruitment                    July 2006 to June 2009                                                                                                                          January 2006 to December 2011                                                                                                        February 2012 to December 2015                                                                                  April 2014 to March 2016                                                                                      September 2012 to August 2014
  Study design                            Prospective population-based case-control                                                                                                       Prospective population-based case-control                                                                                            Prospective population-based case-control                                                                       Prospective population-based case-control                                                                     Nested case-control with uncontrolled cohort
  Population                              Non-anomalous singleton pregnancy, ≥28 weeks' gestation, from three health regions in Auckland, New Zealand                                     Non-anomalous singleton pregnancy, ≥32 weeks' gestation, from nine tertiary maternity facilities in metropolitan Sydney, Australia   Non-anomolous singleton pregnancy, ≥28 weeks' gestation, from seven health regions throughout New Zealand       Non-anomalous singleton pregnancy, ≥28 weeks' gestation, from 41 maternity facilities in the United Kingdom   Singleton pregnancy, ≥28 weeks' gestation, fluent in English, from 16 high, middle, and low income countries
  Stated main outcome measure             Maternal snoring, daytime sleepiness, and sleep position at the time of going to sleep and on waking (left side, right side, back, and other)   Risk factors for late-pregnancy stillbirth with a particular focus on those risks that are potentially modifiable                    The adjusted odds of late stillbirth associated with self-reported going-to-sleep position, on the last night   Maternal sleep practices pregnancy                                                                            To investigate, in an international cohort, whether maternal sleep practices are related to late stillbirth
  Measured sleep-related factors          Sleep position (going-to-sleep, waking)                                                                                                         Sleep position                                                                                                                       Sleep position (going-to-sleep, waking)                                                                         Sleep position (going-to-sleep, waking)                                                                       Sleep position (going-to-sleep, waking)
  Snoring presence                                                                                                                                                                        Snoring presence                                                                                                                     Snoring presence                                                                                                Snoring presence                                                                                              
  Sleep duration                          Snoring presence                                                                                                                                Sleep duration                                                                                                                       Sleep duration                                                                                                  Sleep duration                                                                                                
  Sleep quality                           Sleep duration                                                                                                                                  Sleep quality                                                                                                                        Sleep quality                                                                                                   Sleep quality                                                                                                 
  Sleep restlessness                      Sleep quality                                                                                                                                   Sleep restlessness                                                                                                                   Sleep restlessness                                                                                              Sleep restlessness                                                                                            
  Getting up to toilet                    Sleep restlessness                                                                                                                              Getting up to toilet                                                                                                                 Getting up to toilet                                                                                            Getting up to toilet                                                                                          
  Daytime naps                            Getting up to toilet                                                                                                                            Daytime naps                                                                                                                         Daytime naps                                                                                                    Daytime naps                                                                                                  
  Epworth Sleepiness Scale                Daytime naps                                                                                                                                    Epworth Sleepiness Scale                                                                                                             Epworth Sleepiness Scale                                                                                        Epworth Sleepiness Scale                                                                                      
  Sleep apnoea                            Epworth Sleepiness Scale                                                                                                                        Berlin Questionnaire                                                                                                                 Berlin Questionnaire                                                                                            Berlin Questionnaire                                                                                          
  Night waking                            Berlin Questionnaire                                                                                                                            Night waking                                                                                                                         \-                                                                                                              Night waking                                                                                                  
  \-                                      \-                                                                                                                                              Restless legs                                                                                                                        Restless legs                                                                                                   Restless legs                                                                                                 
  \-                                      \-                                                                                                                                              Sleep latency                                                                                                                        Sleep latency                                                                                                   Sleep latency                                                                                                 
  \-                                      \-                                                                                                                                              Position changes                                                                                                                     Position changes                                                                                                Position changes                                                                                              
  \-                                      \-                                                                                                                                              Insomnia                                                                                                                             Insomnia                                                                                                        Insomnia                                                                                                      
  \-                                      \-                                                                                                                                              Bed size and side                                                                                                                    Bed size and side                                                                                               Bed size and side                                                                                             
  \-                                      \-                                                                                                                                              Pillow(s) placement                                                                                                                  Pillow(s) placement                                                                                             Pillow(s) placement                                                                                           
  \-                                      \-                                                                                                                                              Sleep partners                                                                                                                       Sleep partners                                                                                                  Sleep partners                                                                                                
  \-                                      \-                                                                                                                                              Sleep advice                                                                                                                         Sleep advice                                                                                                    \-                                                                                                            
  \-                                      \-                                                                                                                                              \-                                                                                                                                   Sleep medication                                                                                                Sleep medication                                                                                              
  \-                                      \-                                                                                                                                              Sleep chronotype                                                                                                                     \-                                                                                                              \-                                                                                                            
  Time frames of measured sleep factors   Pre-pregnancy                                                                                                                                   Pre-pregnancy                                                                                                                        \-                                                                                                              Pre-pregnancy                                                                                                 Pre-pregnancy
  During pregnancy                        During pregnancy                                                                                                                                During pregnancy                                                                                                                     During pregnancy                                                                                                During pregnancy                                                                                              
  Last month                              Last month                                                                                                                                      \-                                                                                                                                   Last 4 weeks                                                                                                    Last 4 weeks                                                                                                  
  \-                                      Last two weeks                                                                                                                                  Last week                                                                                                                            \-                                                                                                              \-                                                                                                            
  \-                                      \-                                                                                                                                              \-                                                                                                                                   Last week                                                                                                       Last week                                                                                                     
  Last night                              \-                                                                                                                                              Last night                                                                                                                           Last night                                                                                                      Last night                                                                                                    
  Data collection                         Interview and clinical records                                                                                                                  Interview and clinical records                                                                                                       Interview and clinical records                                                                                  Interview and clinical records                                                                                Online survey

The interaction between supine going-to-sleep position and common measures of SDB (habitual snoring and the BQ) and sleep duration were assessed in bi-variable regression models. Significant interactions were then added to the multivariable model as described above. Estimates of the risk of late stillbirth were reported as odds ratio (OR) with 95% confidence intervals (95% CI). For missing data in each individual study, imputation was not undertaken. Statistical analyses were performed using SAS, version 9.4 (SAS Institute Inc., Cary NC USA).

Each individual study obtained ethical approval \[[@pone.0230861.ref026], [@pone.0230861.ref027], [@pone.0230861.ref030]--[@pone.0230861.ref032]\]. Approval for the IPD meta-analysis was obtained from the New Zealand Health and Disability Ethics Committee (NTX/06/05/054/AM06).

Results {#sec008}
=======

Participants comprised 851 late stillbirth cases and 2257 controls with ongoing pregnancies from five eligible case-control studies ([Fig 1](#pone.0230861.g001){ref-type="fig"}): the Auckland Stillbirth Study \[[@pone.0230861.ref026]\], the New Zealand Multicentre Stillbirth Study \[[@pone.0230861.ref031]\], the Sydney Stillbirth Study \[[@pone.0230861.ref027]\], the UK Midlands and North of England Stillbirth Study \[[@pone.0230861.ref030]\], and the International Study of Trends and Associated Risks for Stillbirth Study \[[@pone.0230861.ref032]\], comprising women of many ethnicities \[[@pone.0230861.ref024]\].

![PRISMA study population flow chart.\
Adapted from EClinicalMedicine, Vol 10, Authors: Cronin, RS., Li, M., Thompson, JMD., Gordon, A., Raynes-Greenow, CH., Heazell, AEP., Stacey, T., Culling, VM., Bowring, V., Anderson, NH., O'Brien, LM., Mitchell, EA., Askie, LM., McCowan, LME, An Individual Participant Data Meta-analysis of Maternal Going-to-Sleep Position, Interactions with Fetal Vulnerability, and the Risk of Late Stillbirth, Pages 49--57., Copyright (2019), with permission from Elsevier.](pone.0230861.g001){#pone.0230861.g001}

Differences in maternal and pregnancy characteristics, infant size, and going-to-sleep position between cases and controls have been previously reported ([S1 Table](#pone.0230861.s002){ref-type="supplementary-material"}) \[[@pone.0230861.ref024]\]. 'Any' snoring (cases n = 473, 56.0%; controls, n = 1182, 54.1%), sleep quality (fairly bad to very bad, cases n = 248, 33.5%; controls, n = 703, 35.3%), daytime sleepiness (positive ESS score ≥10, cases n = 128, 17.5%; controls n = 312, 15.8%), and frequency of getting up to use the toilet (≥1 per night, cases n = 667, 90.0%; controls, n = 1820, 91.5%) last month were not associated with late stillbirth in the univariable analysis.

Long sleep duration \>9 hours last month (cases n = 78, 10.5%; controls, n = 129, 6.5%) was independently associated with late stillbirth compared to sleep duration of 6 to 9 hours (adjusted odds ratio \[aOR\] 1.82, 95% CI 1.14--2.90) ([Table 2](#pone.0230861.t002){ref-type="table"}). Reporting a daily daytime nap last month (cases n = 139, 23.7%; controls, n = 216, 12.8%) compared to never reporting a daytime nap was associated with an increase in the odds of late stillbirth (aOR 1.52, 95% CI 1.02--2.28). In addition, a positive BQ (cases n = 176, 30.0%; controls, n = 370, 21.8%) was associated with late stillbirth (aOR 1.44, 95% CI 1.02--2.04), however, when BMI \>30 was removed from the BQ score, a positive BQ showed no significant association with stillbirth (aOR 0.81, 95% CI 0.54--1.21). Restless sleep greater than average last month (cases n = 225, 38.3%; controls, n = 761, 45.2%) was associated with a reduction in the odds of late stillbirth (aOR 0.62, 95% CI 0.44--0.88).

10.1371/journal.pone.0230861.t002

###### Subjective indicators of sleep-disordered breathing and maternal sleep patterns in participating case-control studies and pooled IPD meta-analysis.

![](pone.0230861.t002){#pone.0230861.t002g}

                                                                          TASS Stacey et al (2011) \[[@pone.0230861.ref026]\]   SSS Gordon et al (2015) \[[@pone.0230861.ref027]\]   MCSS McCowan et al (2017)\[[@pone.0230861.ref031]\]   MiNESS Heazell et al (2017) \[[@pone.0230861.ref030]\]   STARS O'Brien et al (2018) \[[@pone.0230861.ref032]\]   Collaborative Individual Participant Data of Going-to-sleep and Stillbirth (CRIBSS) analysis                                                                                                          
  ----------------------------------------------------------------------- ----------------------------------------------------- ---------------------------------------------------- ----------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------- ---------------------------------------------------------------------------------------------- ------------ ------------ ------------ ------------ ------------ ------------- ----------------------- ---------------------------
  **Going-to-sleep position (last two weeks)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Non-supine                                                              104 (87.4)                                            242 (94.5)                                           84 (89.4)                                             183 (97.9)                                               139 (88.0)                                              539 (96.4)                                                                                     254 (93.0)   698 (96.7)   124 (96.9)   355 (97.0)   705 (91.3)   2017 (96.5)   1                       1
  Supine                                                                  15 (12.6)                                             14 (4.5)                                             10 (10.6)                                             4 (2.1)                                                  19 (12.0)                                               20 (3.6)                                                                                       19 (7.0)     24 (3.3)     4 (3.1)      11 (3.0)     67 (8.7)     73 (3.5)      **2.85 (2.01--4.05)**   **3.06 (1.77--5.28)**
  **Snoring 'any' (during pregnancy)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  No                                                                      86 (55.5)                                             175 (57.6)                                           49 (47.6)                                             93 (48.4)                                                59 (36.2)                                               255 (45.5)                                                                                     118 (41.0)   300 (41.2)   59 (43.7)    179 (44.8)   371 (44.0)   1002 (45.9)   1                       **-**
  Yes                                                                     69 (44.5)                                             129 (42.4)                                           54 (52.4)                                             99 (51.6)                                                104 (63.8)                                              305 (54.5)                                                                                     170 (59.0)   428 (58.8)   76 (56.3)    221 (55.2)   473 (56.0)   1182 (54.1)   1.11 (0.95--1.31)       **-**
  **Habitual snoring ≥ 3 nights/week (last month)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  No                                                                      \-                                                    \-                                                   \-                                                    \-                                                       129 (79.1)                                              494 (88.2)                                                                                     192 (74.7)   544 (81.1)   95 (76.6)    286 (76.5)   416 (76.5)   1324 (82.5)   1                       1
  Yes                                                                     \-                                                    \-                                                   \-                                                    \-                                                       34 (20.9)                                               66 (11.8)                                                                                      65 (25.3)    127 (18.9)   29 (23.4)    88 (23.5)    128 (23.5)   281 (17.5)    **1.40 (1.10--1.78)**   1.04 (0.74--1.47)
  **Berlin Questionnaire**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  Negative screen                                                         \-                                                    \-                                                   \-                                                    \-                                                       106 (65.0)                                              463 (82.7)                                                                                     195 (67.7)   534 (72.9)   110 (80.9)   331 (81.7)   411 (70.0)   1328 (78.2)   1                       1
  Positive screen                                                         \-                                                    \-                                                   \-                                                    \-                                                       57 (35.0)                                               97 (17.3)                                                                                      93 (32.3)    199 (27.2)   26 (19.1)    74 (18.3)    176 (30.0)   370 (21.8)    **1.52 (1.22--1.89)**   **1.44 (1.02--2.04)**
  **Restless sleep (last month)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Less than average                                                       \-                                                    \-                                                   \-                                                    \-                                                       73 (44.8)                                               276 (49.3)                                                                                     109 (37.8)   214 (29.3)   47 (34.6)    95 (24.2)    229 (39.0)   585 (34.7)    1.00 (0.77--1.28)       1.08 (0.78--1.50)
  Average                                                                 \-                                                    \-                                                   \-                                                    \-                                                       41 (25.1)                                               127 (22.7)                                                                                     61 (21.2)    110 (15.0)   31 (22.8)    101 (25.7)   133 (22.7)   338 (20.1)    1                       1
  Greater than average                                                    \-                                                    \-                                                   \-                                                    \-                                                       49 (30.1)                                               157 (28.0)                                                                                     118 (41.0)   407 (55.7)   58 (42.6)    197 (54.1)   225 (38.3)   761 (45.2)    **0.75 (0.59--0.97)**   **0.62 (0.44--0.88)**
  **Sleep duration overnight (last month)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  \<6 hours                                                               30 (19.4)                                             45 (14.8)                                            \-                                                    \-                                                       27 (16.5)                                               79 (14.1)                                                                                      78 (27.1)    212 (29.1)   7 (5.1)      46 (11.4)    142 (19.1)   382 (19.1)    1.06 (0.85--1.33)       0.77 (0.55--1.07)
  6--9 hours                                                              104 (67.1)                                            233 (76.6)                                           \-                                                    \-                                                       123 (75.5)                                              452 (80.7)                                                                                     179 (62.1)   477 (65.5)   116 (85.3)   321 (79.9)   522 (70.4)   1483 (74.4)   1                       1
  \>9 hours                                                               21 (13.5)                                             26 (8.6)                                             \-                                                    \-                                                       13 (8.0)                                                29 (5.2)                                                                                       31 (10.8)    39 (5.4)     13 (9.6)     35 (8.7)     78 (10.5)    129 (6.5)     **1.67 (1.23--2.26)**   **1.82 (1.14**--**2.90)**
  **Daytime naps (last month)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  Never                                                                   \-                                                    \-                                                   \-                                                    \-                                                       33 (26.4)                                               109 (28.0)                                                                                     56 (44.8)    157 (40.4)   36 (28.8)    123 (31.6)   125 (21.3)   389 (23.1)    1                       1
  Occasionally                                                            \-                                                    \-                                                   \-                                                    \-                                                       63 (32.1)                                               248 (36.1)                                                                                     96 (49.0)    333 (48.4)   37 (18.9)    107 (15.6)   196 (33.4)   688 (40.8)    0.90 (0.69--1.17)       0.92 (0.66--1.30)
  Often                                                                   \-                                                    \-                                                   \-                                                    \-                                                       28 (22.1)                                               133 (33.8)                                                                                     66 (52.0)    149 (37.8)   33 (26.0)    112 (28.4)   127 (21.6)   394 (23.4)    1.03 (0.77--1.38)       0.91 (0.62--1.33)
  Everyday                                                                \-                                                    \-                                                   \-                                                    \-                                                       39 (28.1)                                               70 (32.4)                                                                                      70 (50.4)    93 (43.1)    30 (21.6)    53 (24.5)    139 (23.7)   216 (12.8)    **2.06 (1.52--2.78)**   **1.52 (1.02--2.28)**
  **Daytime sleepiness screen (Epworth Sleepiness Scale) (last month)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Negative \<10                                                           136 (87.7)                                            270 (88.8)                                           \-                                                    \-                                                       129 (79.0)                                              479 (85.5)                                                                                     244 (85.3)   612 (84.0)   96 (74.4)    302 (79.0)   604 (82.5)   1660 (84.2)   1                       \-
  Positive ≥10--15                                                        16 (10.3)                                             29 (9.5)                                             \-                                                    \-                                                       25 (15.4)                                               68 (12.2)                                                                                      33 (11.5)    93 (12.7)    24 (18.6)    61 (16.0)    98 (13.4)    251 (12.7)    1.09 (0.84--1.41)       \-
  Positive \>15                                                           3 (1.9)                                               5 (1.6)                                                                                                                                                             9 (5.6)                                                 13 (2.3)                                                                                       9 (3.2)      24 (3.3)     9 (7.0)      19 (5.0)     30 (4.1)     61 (3.1)      1.41 (0.89--2.23)       \-
  **Sleep quality (last month)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Very good                                                               20 (12.9)                                             32 (10.5)                                            \-                                                    \-                                                       25 (15.3)                                               92 (16.4)                                                                                      33 (11.5)    49 (6.7)     9 (6.7)      18 (4.5)     87 (11.7)    191 (9.6)     1.26 (0.94--1.67)       \-
  Good to average                                                         79 (51.0)                                             170 (55.9)                                           \-                                                    \-                                                       98 (60.1)                                               362 (64.6)                                                                                     146 (50.7)   377 (51.5)   83 (61.5)    190 (47.9)   406 (54.8)   1099 (55.1)   1                       \-
  Fairly bad                                                              42 (27.1)                                             79 (26.0)                                            \-                                                    \-                                                       27 (16.6)                                               80 (14.3)                                                                                      82 (28.5)    220 (30.1)   33 (24.4)    159 (40.1)   184 (24.8)   538 (27.0)    0.93 (0.75--1.14)       \-
  Very bad                                                                14 (9.0)                                              23 (7.6)                                             \-                                                    \-                                                       13 (8.0)                                                26 (4.7)                                                                                       27 (9.4)     86 (11.8)    10 (7.4)     30 (7.6)     64 (8.7)     165 (8.3)     1.03 (0.75--1.42)       \-
  **Frequency of getting up to use the toilet overnight (last month)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  \<1                                                                     19 (12.3)                                             36 (11.8)                                            \-                                                    \-                                                       12 (3.4)                                                39 (7.0)                                                                                       38 (13.2)    78 (10.6)    5 (3.7)      16 (4.1)     74 (10.0)    169 (8.5)     1.07 (0.80--1.45)       **-**
  ≥1                                                                      136 (87.7)                                            268 (88.2)                                           \-                                                    \-                                                       151 (92.6)                                              521 (93.0)                                                                                     250 (86.8)   655 (89.4)   130 (96.3)   376 (95.9)   667 (90.0)   1820 (91.5)   1                       **-**

Data are number (percentage) or median (IQR). TASS = The Auckland Stillbirth Study. SSS = Sydney Stillbirth Study. MCSS = New Zealand Multicentre Stillbirth Study. MiNESS = Midlands and North of England Stillbirth Study. STARS = Study of Trends and Associated Risks for Stillbirth Study. Participants with missing data were excluded from the multivariable models. No imputation for missing data. Multivariable models are adjusted for matching terms (gestation at interview or survey in controls, and diagnosis of stillbirth for cases), study and site, age, BMI, ethnicity, parity, education, marital status, pre-existing hypertension or diabetes, smoking, drug use, baby birthweight centile, fetal movement, supine going-to-sleep position, habitual snoring, the Berlin Questionnaire, restless sleep, sleep duration, and daytime naps.

Women who had a stillbirth, 689 cases from four participating studies \[[@pone.0230861.ref027], [@pone.0230861.ref030]--[@pone.0230861.ref032]\], were asked what time of day they thought their baby had died: 34.8% (n = 240, or 52.3% of 459 cases who could recall a time of day) reported that they thought their baby had died overnight, 19.4% (n = 134) reported afternoon-evening, 11.8% (n = 81) morning, 0.6% (n = 4) during a daytime nap, and 33.4% (n = 230) were unsure ([Fig 2](#pone.0230861.g002){ref-type="fig"}).

![Women who had a stillbirth and their perception of timing of the death.\
Data are n = 689.](pone.0230861.g002){#pone.0230861.g002}

Interactions were assessed between supine going-to-sleep position and habitual snoring, a positive BQ including BMI, sleep duration \>9 hours, and restless sleep greater than average last month ([Table 3](#pone.0230861.t003){ref-type="table"}). Interactions for a positive BQ (p = 0.56), sleep duration \>9 hours (p = 0.99), and restless sleep greater than average (p = 0.98) were not statistically significant. There was a significant interaction between habitual snoring and supine going-to-sleep position (multivariable interaction p value = 0.001). The combined effect of supine going-to-sleep position and habitual snoring resulted in a reduced odds of late stillbirth in the multivariable model than would be expected. ([Table 3](#pone.0230861.t003){ref-type="table"}).

10.1371/journal.pone.0230861.t003

###### Analysis for interaction between supine going-to-sleep position, and habitual snoring, the Berlin Questionnaire, sleep duration \>9 hours and restless sleep greater than average.

![](pone.0230861.t003){#pone.0230861.t003g}

                                            Sleep factor   Supine position   n      \%                  Univariable odds ratio (95% CI)   Univariable interaction p value   Multivariable odds ratio (95% CI)   Multivariable interaction p value
  ----------------------------------------- -------------- ----------------- ------ ------------------- --------------------------------- --------------------------------- ----------------------------------- -----------------------------------
  **Habitual snoring**                      Yes            Yes               17     0.8                 1.44 (0.50--4.18)                 **0.04**                          1.03 (0.29--3.64)                   **0.001**
  Yes                                       No             382               18.4   1.49 (1.16--1.92)   1.17 (0.82--1.66)                                                                                       
  No                                        Yes            75                3.6    3.37 (2.08--5.45)   3.75 (2.02--6.95)                                                                                       
  No                                        No             1606              77.2   1                   1                                                                                                       
  **Positive Berlin Questionnaire**         Yes            Yes               22     1.0                 3.44 (1.45--8.12)                 0.56                              \-                                  \-
  Yes                                       No             510               23.1   1.56 (1.24--1.95)   \-                                                                                                      
  No                                        Yes            75                3.4    2.96 (1.83--4.80)   \-                                                                                                      
  No                                        No             1599              72.5   1                   \-                                                                                                      
  **Sleep duration \>9hrs**                 Yes            Yes               12     0.5                 4.10 (1.28--13.13)                0.99                              \-                                  \-
  Yes                                       No             178               6.9    1.55 (1.11--2.15)   \-                                                                                                      
  No                                        Yes            114               4.4    2.63 (1.78--3.88)   \-                                                                                                      
  No                                        No             2271              88.2   1                   \-                                                                                                      
  **Restless sleep greater than average**   Yes            Yes               34     1.5                 1.19 (0.56--2.54)                 0.10                              \-                                  \-
  Yes                                       No             916               41.7   3.45 (2.05--5.80)   \-                                                                                                      
  No                                        Yes            63                2.9    0.75 (0.61--0.93)   \-                                                                                                      
  No                                        No             1186              53.9   1                   \-                                                                                                      

Participants with missing data were excluded from the analysis. No imputation for missing data.

Discussion {#sec009}
==========

Main findings {#sec010}
-------------

Our study has demonstrated that a positive BQ, long sleep duration \>9 hours, and a daily daytime nap in the last month, were each associated with increased odds of late stillbirth. In contrast, restless sleep greater than average in the last month was protective for late stillbirth. The associations between these aspects of maternal sleep and late stillbirth were adjusted for prespecified covariates \[[@pone.0230861.ref038]\] available in all the studies (S 1), and measures of SDB and maternal sleep patterns significant in univariable analysis ([Table 1](#pone.0230861.t001){ref-type="table"}).

The \~50% prevalence of 'any' snoring and habitual snoring ≥3 nights per week between 17--24% was within the range reported in the pregnancy literature \[[@pone.0230861.ref004], [@pone.0230861.ref043]--[@pone.0230861.ref046]\]. 'Any' snoring, habitual snoring, sleep quality, and daytime sleepiness using the ESS, was not associated with late stillbirth ([Table 2](#pone.0230861.t002){ref-type="table"}). This is consistent with previous studies: snoring \[[@pone.0230861.ref026], [@pone.0230861.ref027], [@pone.0230861.ref033]\], sleep quality \[[@pone.0230861.ref033]\], and daytime sleepiness \[[@pone.0230861.ref047]\].

A positive BQ was independently associated with late stillbirth ([Table 2](#pone.0230861.t002){ref-type="table"}), although this association was no longer significant when BMI \>30 was excluded from the BQ (Model 2). This aligns with the suggestion \[[@pone.0230861.ref048], [@pone.0230861.ref049]\] that the BQ used in pregnant women is a proxy for BMI during late pregnancy, due to BMI being a component of the BQ. Indeed, the BQ performs poorly as a screening tool for objective SDB measures during pregnancy, with a 2018 meta-analysis \[[@pone.0230861.ref047]\] of six studies (n = 604 participants) reporting poor to fair BQ performance during pregnancy with an overall probability of OSA occurrence of 38% if a pregnant woman has a positive BQ. This range may be due to the BQ including risk factors that do not apply to pregnant women (male gender, age \>50 years) and because weight gain is relevant for all pregnancies. Furthermore, symptoms of SDB progress with gestation, and there are differing opinions about the optimal timing of the BQ during pregnancy \[[@pone.0230861.ref047]\].

Long sleep duration \>9 hours was also associated with late stillbirth ([Table 2](#pone.0230861.t002){ref-type="table"}), and this association has previously been reported in two case-control studies \[[@pone.0230861.ref026], [@pone.0230861.ref032]\]. While the reason is uncertain, it is plausible that prolonged periods of aortocaval compression \[[@pone.0230861.ref036], [@pone.0230861.ref037]\] during maternal sleep may be a factor. It is also possible that an unmeasured confounder associated with long third trimester sleep (e.g. working night shifts or no paid employment) \[[@pone.0230861.ref050]\] may lengthen the duration of maternal sleep over the last month and contribute to stillbirth. The definition of long duration in the individual case-control studies is also inconsistent, ranging from \>8 hours \[[@pone.0230861.ref026]\] to \>9 hours \[[@pone.0230861.ref032]\]. This range may be due to lack of consensus about what is considered normal sleep duration in healthy pregnancy \[[@pone.0230861.ref051]\], although self-reported time to sleep in the third trimester is similar to objectively measured sleep duration \[[@pone.0230861.ref051]\] and maternal estimates of sleep duration increases in accuracy with increasing duration of sleep \[[@pone.0230861.ref052]\]. There was no association between short sleep duration during last month and late stillbirth, despite an independent association with short sleep on the night before stillbirth in three case-control studies \[[@pone.0230861.ref026], [@pone.0230861.ref030], [@pone.0230861.ref031]\]. This discrepancy may be due to a potentially fatal fetal event (e.g. pre-labour contractions for an acutely compromised fetus) that may shorten sleep on the night before stillbirth \[[@pone.0230861.ref053]\].

Daily daytime naps were also associated with a 1.5-fold increase in the odds of late stillbirth compared with no daytime naps ([Table 2](#pone.0230861.t002){ref-type="table"}), and this finding is consistent with individual studies \[[@pone.0230861.ref026], [@pone.0230861.ref030], [@pone.0230861.ref031]\]. The physiology behind this is unknown and cannot be explained by overnight sleep duration or daytime sleepiness, as daily naps remained significant when we controlled for these factors. However, we speculate that daily naps in late pregnancy may increase the duration of maternal inactivity, potentially increasing the amount of time that the women spend in the supine position and therefore the duration of aortocaval compression, which when combined with the blood pressure dips that occur during third trimester sleep \[[@pone.0230861.ref054]\], may further compromise a vulnerable fetus \[[@pone.0230861.ref034]\].

Our finding of a 38% reduction in the odds of late stillbirth for women who reported restless sleep more than average during the last month is novel ([Table 2](#pone.0230861.t002){ref-type="table"}). We speculate that this may be due to maternal body movement facilitating maternal-fetal blood flow, potentially abating adverse fetal effects of aortocaval compression \[[@pone.0230861.ref037], [@pone.0230861.ref055]\]. Furthermore, while maternal hypotension is known to have adverse fetal consequences, such as lower birth weight and stillbirth \[[@pone.0230861.ref056]--[@pone.0230861.ref059]\], increased third trimester arousals related to snoring \[[@pone.0230861.ref060]\] may assuage prolonged periods of relative hypotension, as deep sleep is commensurate with the lowest overnight blood pressure and arousal with increased blood pressure \[[@pone.0230861.ref061]\]. Our finding of a protective association between restless sleep more than average and late stillbirth aligns with an international case-control study \[[@pone.0230861.ref032]\] that reported non-restless sleep in the last month was associated with a 1.7-fold increase in odds of late stillbirth. Similarly, getting up to use the toilet on the night before stillbirth is associated with a 2-fold reduction in late stillbirth \[[@pone.0230861.ref026], [@pone.0230861.ref030], [@pone.0230861.ref031]\], suggesting that maternal body movement on the night before stillbirth may mitigate the effects of a hypoxic event on the fetus \[[@pone.0230861.ref062]\].

Certainly, pregnant women are susceptible to the development of sleep disturbances, commonly reduced quality and duration of sleep, night waking, daytime sleepiness, and snoring \[[@pone.0230861.ref045], [@pone.0230861.ref063]\]. Causes are most likely to be hormonal and physiological changes of pregnancy, including increased oxygen consumption and metabolic rate, lower overall oxygen reserve, nasopharyngeal oedema, vasomotor rhinitis, and weight gain, which contribute to narrowing of upper airway, reduced functional residual capacity due to diaphragmatic pressure by the growing fetus, and increased arousals during sleep \[[@pone.0230861.ref060], [@pone.0230861.ref063]\]. These physiological changes are exacerbated as pregnancy progresses and when combined with obesity, advanced maternal age, and supine sleep position \[[@pone.0230861.ref064]--[@pone.0230861.ref066]\].

Conversely, late pregnancy may provide some protection from SDB, with increased respiratory drive \[[@pone.0230861.ref067]\], alteration in the cyclical sleep pattern with decreased rapid eye movement (REM) sleep \[[@pone.0230861.ref060], [@pone.0230861.ref063], [@pone.0230861.ref068]\], and preference for a lateral sleep position \[[@pone.0230861.ref026], [@pone.0230861.ref030], [@pone.0230861.ref045], [@pone.0230861.ref069]\]. These may be factors contributing to our finding of a significant interaction between habitual snoring during the last month and supine going-to-sleep position, with a lower odds of late stillbirth than expected in women who reported both during the last month. While this may be a chance finding due to low prevalence, with 17 (12 controls and 5 cases) of 92 women reporting habitual snoring and a supine going-to-sleep position, this could also be explained by the women being woken by a sleep companion or experiencing a self-arousal due to snoring, and moving from the supine to a lateral position, which is known to reduce third trimester snoring in obese women \[[@pone.0230861.ref023]\] and late stillbirth risk \[[@pone.0230861.ref024]\].

Strengths and limitations {#sec011}
-------------------------

A limitation of the IPD meta-analysis is that not all participating studies had data for all sleep measures. Minor differences in the design of the individual studies also limited the inclusion of some covariates. Our search had no language restriction and an eligible study from India was identified, however, there was no response from authors or journal editors to repeated invitations to participate. No other eligible randomised trials, prospective cohort studies or studies from low-income countries were identified, thus participating studies were all case-control studies from high-income countries. A limitation of case-control studies include the retrospective data collection which is subject to potential recall bias, although as the relationship between late stillbirth and maternal sleep is not universally well known by pregnant women, systematic bias is unlikely. The longer length of time before interview for cases may have influenced their recall compared to controls, however, case recall is unlikely to be biased towards an association with SDB, with self-reports from a single night of sleep having similar bias and calibration as 'usual' sleep \[[@pone.0230861.ref070]\]. Use of self-reported symptoms of SDB, rather than objective measures using polysomnography may also be considered a limitation. However, self-report of snoring is strongly and reliably associated with the severity of OSA obtained from polysomnography in non-pregnant \[[@pone.0230861.ref071]\] and pregnant women \[[@pone.0230861.ref046]\], therefore self-report is useful for large scale studies where routine access to polysomnography in late pregnancy is costly and impractical.

Conclusion {#sec012}
==========

This IPD meta-analysis adds to the evidence on maternal sleep and late stillbirth, using the best available data on the association of SDB and maternal sleep patterns with the risk of late stillbirth. These findings demonstrate that self-reported maternal snoring, a positive BQ screen excluding BMI, daytime sleepiness, sleep quality, and getting up to use the toilet, are not independently associated with late stillbirth last month. Long sleep duration \>9 hours and daily daytime naps are independent risk factors, while sleep more restless than average may reduce the odds of late stillbirth. There is an urgent need to better understand factors associated with long sleep duration and daily daytime naps before recommendations can be made to pregnant women. Meanwhile, pregnant women may be reassured that the commonly reported increased restlessness of sleep during late pregnancy may be physiological and is associated with a reduced risk of late stillbirth.
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-You report that the combined effect of supine going-to-sleep position and habitual snoring resulted in a reduced odds of late stillbirth in the multivariable model and you explain this result assuming that snoring can cause arousal that can cause a change of position from supine to lateral. It would be interesting to test this hypothesis with an objective assessment of the position.

-You report that getting up to use the toilet in the night is associated with a reduced risk of late stillbirth, suggesting that maternal body movement on the night may mitigate the effects of a hypoxic event on the fetus. Considering that getting up to use the toilet in the night can be also a clinical manifestation of SBD, have you analyzed interactions between the use of the toilet in the night and Berlin Questionnaire (excluding BMI)?

-Non using objective measures (polysomnography) for SBD's evaluation may be a limitation as you specified. Didn't you evaluate the possibility to assess the polysomography, if not possibile in all the women, in some of them such as patients with positive Berlin Questionnaire (excluding BMI), in patients with restless sleep and in patients getting up to use the toilet?

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: Yes: Dott.ssa Francesca Furia

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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The authors thank the editorial team and reviewers' for their comments. The manuscript has been revised according to the comments.

EDITORIAL FEEDBACK

1\) When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

\- AUTHOR RESPONSE: We agree, and have addressed these additional requirements.

2\) Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: <http://journals.plos.org/plosone/s/supporting-information>

\- AUTHOR RESPONSE: We agree, and have added detail to the captions for the Supporting Information files at the end of our manuscript.

3\) Thank you for stating the following in the Financial Disclosure section... We note that you received funding from a commercial source: ResMed. Please provide an amended Competing Interests Statement that explicitly states this commercial funder, along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc. Within this Competing Interests Statement, please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: \"This does not alter our adherence to PLOS ONE policies on sharing data and materials." (as detailed online in our guide for authors <http://journals.plos.org/plosone/s/competing-interests>). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your amended Competing Interests Statement within your cover letter. We will change the online submission form on your behalf.

\- AUTHOR RESPONSE: We agree, and have amended our Competing Interests Statement as follows:

"Associate Professor O\'Brien reports grants from ResMed outside the submitted work. This does not alter our adherence to PLOS ONE policies on sharing data and materials."

This amended Competing Interests Statement has been included within our cover letter. Thank you for changing the online submission form on our behalf.

4\) We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see <http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions>.

In your revised cover letter, please address the following prompts:

a\) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b\) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see <http://www.bmj.com/content/340/bmj.c181.long> for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see <http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories>.

We will update your Data Availability statement on your behalf to reflect the information you provide.

\- AUTHOR RESPONSE: We have provided additional details regarding the ethical restrictions on sharing our data publicly in our revised cover letter as follows:

"Data cannot be shared publicly beyond the Collaborative Individual Participant Data Meta-analysis of Sleep and Stillbirth (CRIBSS) group as no individual participating study obtained consent from participants to make the data publically available. Furthermore, because stillbirth is uncommon there is potential for participants to be identifiable. Contact information for the CRIBSS Data Access Committee is The CRIBSS Data Centre, Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland Mail Centre, Auckland 1142."

Thank you for updating our Data Availability statement.

REVIEWER FEEDBACK

REVIEWER \# 1

1.1) The aim of this work is to find the relationship of symptom of SDB and late stillbirth from previously done case-control studies that is available and pool them together using statistical technique. The point that this paper is a successful collaboration between large teams around the globe combining with a robust individual patient-level data analysis technique is interesting. I congratulate the authors for their efforts. Overall I find the manuscript to be of good quality, however some minor revision points may need to be done:

\- AUTHOR RESPONSE: Thank you.

1.2) Study selection process report need to be more transparent, i.e. the authors should describe number of study that were excluded (fig. 1 may need to be revised) how many duplicates were there?, why 124 studies did not meet the eligibility criteria? There should be more detail on the number and reason of studies that were excluded, to provided that the author has established all available evidences to support the meta-analysis. Also, for one study that is not participating, is there any difference in characteristic of that particular study compared to participating studies? (The author may need to describe about this in the result)

\- AUTHOR RESPONSE: We agree, and have revised "Figure 1 PRISMA study population flow chart," which now includes the number of duplicate articles, and participant level inclusion and exclusion criteria. We have also added more detail to the Strengths and Limitations section as follows:

"Our search had no language restriction and an eligible study from India was identified, however, there was no response from authors or journal editors to repeated invitations to participate. No other eligible randomised trials, prospective cohort studies or studies from low-income countries were identified, thus participating studies were all case-control studies from high-income countries."

Please note that a December 23, 2019 update for Beall\'s List of Predatory Journals and Publishers states that the journal that published the non-participating study from India (the International Journal of Reproduction, Contraception, Obstetrics and Gynecology) has been included with "journals that were not originally on the Beall\'s list but may be predatory." <https://beallslist.net/standalone-journals/>

1.3) Case control studies were prone to recall bias and combining case-control in meta-analysis can still be susceptible to this. I wonder if there any other supporting evidences from cohort study? If there is not the author should specifically mention about the result of the assessment of quality of the evidence in the result, and emphasis on the possibility of bias upon making conclusion, which may need a large pregnancy cohort to be done.

\- AUTHOR RESPONSE: We agree that case-control studies have the limitation of recall bias, and that supporting evidence from cohort studies should be reported where available. This has been explained in the Strengths and Limitations section, and we have clarified that that it is the relationship between late stillbirth and maternal sleep that is not universally well known as follows:

"A limitation of case-control studies include the retrospective data collection which is subject to potential recall bias, although as the relationship between late stillbirth and maternal sleep is not universally well known by pregnant women, systematic bias is unlikely. The longer length of time before interview for cases may have influenced their recall compared to controls, however, case recall is unlikely to be biased towards an association with SDB, with self-reports from a single night of sleep having similar bias and calibration as 'usual' sleep \[70\]. Use of self-reported symptoms of SDB, rather than objective measures using polysomnography may also be considered a limitation. However, self-report of snoring is strongly and reliably associated with the severity of OSA obtained from polysomnography in non-pregnant \[71\] and pregnant women \[46\]; therefore self-report is useful for large-scale studies where routine access to polysomnography in late pregnancy is costly and impractical."

We also agree that the assessment of the quality of the evidence should be reported. Under the Materials and Methods section, we have already provided a reference to the risk of bias tool and risk of bias report used for this study as follows:

"This IPD meta-analysis was registered with the PROSPERO register of systematic reviews (CRD42017047703) and followed the IPD meta-analysis protocol \[38\], search strategy \[24\], risk of bias for non-randomised studies (ROBINS-E) tool \[39\], and published results \[24\]."

REVIEWER \#2

2.1) How the duration of overnight sleep was evaluated? Did you use a standardized sleep log?

\- AUTHOR RESPONSE: Sleep data, including sleep duration, were collected by self-report in all participating studies. No study collected sleep data via standardised sleep log or actigraphy. To make this clear, we have added the words "self-report" to the Materials and Methods section as follows:

"Maternal sleep data were collected by self-report via face-to-face interview \[26, 27, 30, 31\] or online survey \[32\] within six weeks after stillbirth in cases or at a matched gestation in controls"

2.2) a) How did you evaluated the sleep position (supine and not supine)? Is this data only self-reported? Or did you use some instruments to evaluate it? b) If only self-reported, it can probably be inaccurate because you can't know the real position throughout the night. Can you specify it.

\- AUTHOR RESPONSE:

a\) Please see answer to 2.1.

b\) The participating studies were all questionnaire based, data on maternal sleep position throughout the night was not collected. The supine/non-supine going-to-sleep position variable in our manuscript refers only to going-to-sleep position. The reason that going-to-sleep position was the chosen variable was because this is most easily recalled and modifiable for the majority of women in late pregnancy (Cronin et al., 2017, <https://doi.org/10.1186/s12884-017-1378-5>). We were not able to validate maternal self-report of going-to-sleep position in the individual studies, however, in some of the participating studies the investigators reported that participants often described reference points to remember their going-to-sleep position, such as facing the door. In addition, McIntyre et al's 2016 overnight sleep study of 30 healthy women in late pregnancy (<https://doi.org/10.1186/s12884-016-0905-0>), reported good agreement for going-to-sleep (sleep onset) position between infared digital video and self-completed questionnaires for participants (who were not given any information about sleep position), with the majority accurately recalling their going-to-sleep position.

2.3) You suggest that a reduction in the odds of late stillbirth for women who reported restless sleep during the last month may be is due to maternal body movement facilitating maternal-fetal blood flow, potentially abating adverse fetal effects of aortocaval compression. Considering that the supine position is associated with an increase in aortocaval compression, have you evaluated interactions between restless sleep and sleep position to understand if the reduced risk of late stillbirth in these cases can be related to the position?

\- AUTHOR RESPONSE: We agree that the relationship between restless sleep and supine going-to-sleep position is interesting. Therefore, we have added the analysis of interaction between supine going-to-sleep position and restless sleep greater than average last month to "Table 3: Analysis for interaction between supine going-to-sleep position, and habitual snoring, the Berlin Questionnaire, sleep duration \>9 hours and restless sleep greater than average." The interaction between supine going-to-sleep position and restless sleep was not statistically significant (p=0.98).

2.4) You report that the combined effect of supine going-to-sleep position and habitual snoring resulted in a reduced odds of late stillbirth in the multivariable model and you explain this result assuming that snoring can cause arousal that can cause a change of position from supine to lateral. It would be interesting to test this hypothesis with an objective assessment of the position.

\- AUTHOR RESPONSE: We agree that an objective assessment of sleep position in women with habitual snoring during late pregnancy would be of great interest and could be evaluated in future studies.

2.5) You report that getting up to use the toilet in the night is associated with a reduced risk of late stillbirth, suggesting that maternal body movement on the night may mitigate the effects of a hypoxic event on the fetus. Considering that getting up to use the toilet in the night can be also a clinical manifestation of SBD, have you analyzed interactions between the use of the toilet in the night and Berlin Questionnaire (excluding BMI)?

\- AUTHOR RESPONSE: We agree that we reported that getting up to use the toilet on the night before stillbirth was associated with halving of the odds of late stillbirth in three individual studies. However, there was no association found between getting up to use the toilet during the month before stillbirth in the analysis reported in our manuscript.

2.6) Non using objective measures (polysomnography) for SBD's evaluation may be a limitation as you specified. Didn't you evaluate the possibility to assess the polysomography, if not possibile in all the women, in some of them such as patients with positive Berlin Questionnaire (excluding BMI), in patients with restless sleep and in patients getting up to use the toilet?

\- AUTHOR RESPONSE: The participating studies were all questionnaire based and any referral for polysomnography was not captured.

10.1371/journal.pone.0230861.r003
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